ImmunityBio last closed at $10.38 (+0.92%) on 2026-10-05. Signals today: MA aligned. Listed on Nasdaq. Trailing 12 months PER is -11.0×. Its overall grade ranks 8 of 741 stocks in Healthcare.
About this company
ImmunityBio last closed at $10.38 (+0.92%) on 2026-10-05. Signals today: MA aligned. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A+ · 8/741
Valuation grade A+
Related stocks
- NantKwestRelated theme
ImmunityBio와 같은 창업자·기술축(면역치료)에서 형성된 핵심 연계 기업
- Bristol-Myers SquibbCompetitor
면역항암제·세포치료 영역에서 경쟁하는 대형 제약사
- MerckCompetitor
종양면역치료 시장에서 경쟁하는 대표 빅파마
ETFs holding this stock
Golden Eagle Dynamic Hypergrowth ETF
Details →About ImmunityBio
- What technical signals does ImmunityBio (IBRX) have?
- ImmunityBio current technical signals: MA alignment (score 0.76).
- Is ImmunityBio a cup-and-handle pattern?
- No. ImmunityBio has no valid Cup signal right now.
- What published figures are available for ImmunityBio?
- Market cap: $10.22B. Trailing 12 months PER: -11.0×. Latest quarter PBR: -10.42×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about ImmunityBio, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy